Zenas BioPharma, Inc. Convertible Notes Payable, Noncurrent
Zenas BioPharma, Inc. (ZBIO) had Convertible Notes Payable, Noncurrent of $20.30 million as of 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2025-03-11
- 2023-12-31: Convertible Notes Payable, Noncurrent $20.30M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2023-12-31 | $20.30M 10-K · filed 2025-03-11 |